Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can difficulty naming emotions shape how much tailbone pain you feel?

NCT ID NCT07828145

Knowledge-focused Sponsor: Marmara University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 18, 2026 · Last updated Sep 18, 2026

Summary

Researchers at Marmara University are studying whether alexithymia, a trait where people struggle to identify and describe their feelings, relates to pain intensity, quality of life, anxiety, depression, and childhood trauma in adults with chronic coccydynia. Participants have had tailbone pain for at least three months and are scheduled for a ganglion impar block, a nerve injection used when other treatments fail. Before the procedure, each person completes questionnaires on emotions, pain, mood, and general health. The study aims to clarify how emotional awareness and pain interact, not to test whether the block works.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If a link exists, doctors could one day screen for alexithymia and tailor psychological support alongside pain treatment for people with chronic tailbone pain.
What could go wrong
This is a small, single-center survey of 70 people, so it can show associations but not cause and effect. Findings may not apply to other pain conditions or clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients presenting to Marmara University Pendik Training and Research Hospital, Division of Algology outpatient clinic, who are diagnosed with chronic coccydynia and scheduled for clinically indicated Ganglion Impar Block.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 18 years or older. 2. Clinical diagnosis of chronic coccydynia persisting for at least 3 months. 3. Clinical indication and scheduled for Ganglion Impar Block due to persistent pain refractory to conservative treatments. 4. Literate and possessing sufficient mental capacity to comprehend and complete self-report instruments. 5. Provision of voluntary written informed consent. Exclusion Criteria: 1. Significant cognitive impairment or communication barriers impairing informed consent capacity or questionnaire completion. 2. Active psychotic disorder or current manic episode. 3. Suspected acute self-harm or suicidal risk identified during clinical evaluation. 4. Chronic coccygeal pain secondary to malignancy, acute fractures, or active infection. 5. Severe active psychiatric disease currently under medical treatment (e.g., severe mental illness, schizophrenia, bipolar affective disorder). (Note: Depressive symptoms alone are not an exclusion criterion; they are assessed via HADS and controlled for as covariates in analytical models).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alexithymia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Affective Symptoms alexithymia Chronic Pain chronic pain syndrome coccygodynia Depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alexithymia Chronic pain Coccydynia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Marmara University Pendik Training and Research Hospital

    Istanbul, 34899, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.